I am honored to present the Gynofem Healthcare & Pharmaceuticals Ltd. Annual Report for 2023-2024. This past year has been one of growth, resilience, and progress for our company, as we continue our journey to redefine women's healthcare in India. Our unwavering commitment to improving the health of women, especially in underserved areas, has been the driving force behind every decision we make. Through innovative solutions in gynecology and obstetrics, we are addressing some of the most critical health issues women face, from infertility and pregnancy complications to hormonal imbalances and postpartum health challenges. In FY23-24, we have expanded our reach, bringing high-quality healthcare products to even more regions across India. Our partnerships with over 25,000 retailers, stockists, and 5,000 gynecologists across key states have allowed us to touch the lives of thousands of women in need. Notably, our entry into Maharashtra this year marks a significant milestone in our expansion strategy. We are also proud of our continued investments in research and development, which are focused on improving the quality of care for women. Our research efforts in reproductive health, hormonal balance, and pregnancy care have enabled us to develop cutting-edge solutions that address the needs of today's women. As a result, we've launched new products, including Fertovita and Pregnax, which have been well received by the medical community and patients alike. Looking ahead, we are excited about the future. Our plans for the coming year include not only expanding into new regions but also launching our much-anticipated Pharma + Pathology platform, which will enhance access to diagnostic and healthcare solutions across India. This initiative aligns with our goal to provide holistic care for women at every stage of their life, from conception to postpartum recovery. Our focus remains on sustainable growth, innovation, and making healthcare accessible to every woman in need. I am deeply grateful for the dedication of our team, whose efforts have been integral to our success, and the trust placed in us by our shareholders, partners, and customers. Thank you for your continued support. Together, we will continue to make a lasting impact on women's health, building a healthier and stronger future for India. Sincerely,

We strive to combine research-driven innovation with compassionate care, ensuring every woman has access to safe, effective, and affordable healthcare throughout every stage of life.